We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our
Cookie Policy
.
Accept
Label
Drug Products
Books
FDAnews Books Library
Events
Form 483s Database
Subscription Newsletters
Free Newsletters
Webinar Training Pass
Device Products
Books
FDAnews Books Library
Events
Form 483s Database
Subscription Newsletters
Free Newsletters
Webinar Training Pass
Clinical Products
Advertising
White Papers
Contact Us
About Us
COVID-19
Sign In
Create Account
Sign Out
My Account
Home
» New Parkinson’s Drug Shows Promise
New Parkinson’s Drug Shows Promise
October 21, 2013
Impax Pharmaceuticals’ Parkinson’s disease candidate IPX066 appears to benefit patients just beginning their journeys with the disease.
Medpage Today
Featured Products
Biological Risk Evaluation and Management for Medical Devices
GMP Inspection Preparation Checklist: A Tool for Internal Auditing
Featured Stories
J&J Lands U.S. Government Contract for 100 Million COVID-19 Vaccine Doses
FDA Clears Eyenuk’s Diabetic Retinopathy Screening System
NIH Launches Trial of Remdesivir with Merck’s Rebif for COVID-19
Life Spine Gets FDA Clearance for Lumbar Spacer
The Revised ICH E8:
A Guide to New Clinical Trial Requirements
Learn More
